| |
AD |
NPH |
p-value |
| N |
11 |
11 |
------ |
| Males/Females (n) |
2/9 |
7/4 |
0.47 |
| Age |
61.46±8.24 |
81.36±2.58 |
<0.001 |
| Education |
14.55±2.70 |
15.13±3.52 |
0.93 |
| MMSE |
18.89±8.68 |
19.13±8.32 |
0.92 |
| Aβ 1-42 (pg/ml)† |
290.33±146.74 |
251.17±92.39 |
0.72 |
| Tau (pg/ml)† |
651.53±276.41 |
475.07±335.23 |
0.08 |
| P-tau 181 (pg/ml)† |
79.12±30.00 |
47.35±20.24 |
0.009 |
| ATI † |
0.34±0.34 |
0.43±0.21 |
0.11 |
| Aβ 1-42 (pg/ml)‡ |
260.02 (187.07, 361.41)* |
237.14 (186.64, 300.61)* |
0.721 |
| Tau (pg/ml)‡ |
584.79 (406.44, 839.46)* |
391.74 (256.45, 597.04)* |
0.841 |
| P-tau 181 (pg/ml)‡ |
72.44 (52.12, 100.46)* |
42.85 (30.76, 59.70)* |
0.331 |
| ATI‡ |
0.27 (0.18, 0.41)* |
0.37 (0.26, 0.54)* |
0.571 |
|
